Clinical impact of dyslipidemia for coronary plaque vulnerability in acute coronary syndrome without metabolic syndrome

Journal of Cardiology

Volumn 54, Issue 3, 2009, Pages 394-401

  Kato, Masaya ^a   Dote, Keigo ^a   Sasaki, Shota ^a   Ueda, Kentaro ^a   Kono, Yasuyuki ^a   Naganuma, Toru ^a   Watanabe, Yoshikazu ^a   Kajikawa, Masato ^a   Yokoyama, Haruko ^a   Higashi, Akifumi ^a  

^a HIROSHIMA CITY ASA HOSPITAL   (Japan)

Author keywords

Acute coronary syndrome; Carotid arteries; Metabolic syndrome; Vascular remodeling

Indexed keywords

CHOLESTEROL; CREATINE KINASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BODY MASS; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DISEASE MARKER; DISEASE PREDISPOSITION; DYSLIPIDEMIA; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; THORAX PAIN; TISSUE REGENERATION; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS; VASODILATATION;

ACUTE CORONARY SYNDROME; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERIES; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; SECONDARY PREVENTION;

EID: 70450222734     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.06.007     Document Type: Article

References (29)

1. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001) 2486-2497
2. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
3. Meigs J.B., D'Agostino Sr. R.B., Wilson P.W., Cupples L.A., Nathan D.M., and Singer D.E. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46 (1997) 1594-1600
4. Klein B.E., Klein R., and Lee K.E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25 (2002) 1790-1794
5. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
6. Goldstein J.A., Demetriou D., Grines C.L., Pica M., Shoukfeh M., and O'Neill W.W. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343 (2000) 915-922
7. Lee S.G., Lee C.W., Hong M.K., Kim J.J., Park S.W., and Park S.J. Change of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography. Am Heart J 147 (2004) 281-286
8. Goldstein J.A., Chandra H.R., and O'Neill W.W. Relation of number of complex coronary lesions to serum C-reactive protein levels and major adverse cardiovascular events at one year. Am J Cardiol 96 (2005) 56-60
9. Kato M., Dote K., Sasaki S., Ueda K., Matsuda O., Nakano Y., Naganuma T., and Sugiura T. Coronary plaque vulnerability in metabolic syndrome: assessment of carotid artery morphology in acute coronary syndrome. Circ J 71 (2007) 1229-1233
10. Assmann G., Schulte H., von Eckardstein A., and Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124 Suppl. (1996) S11-S20
11. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., Patsch W., and Atherosclerosis Risk in Communities Study Group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104 (2001) 1108-1113
12. Curb J.D., Abbott R.D., Rodriguez B.L., Masaki K., Chen R., Sharp D.S., and Tall A.R. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 45 (2004) 948-953
13. Olsson A.G., Schwartz G.G., Szarek M., Sasiela W.J., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., and Zeiher A. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J 26 (2005) 890-896
14. Giraldez R.R., Giugliano R.P., Mohanavelu S., Murphy S.A., McCabe C.H., Cannon C.P., and Braunwald E. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis. J Am Coll Cardiol 52 (2008) 914-920
15. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson Jr. S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340 (1999) 14-22
16. Sato S., Makita S., Uchida R., Ishihara S., and Majima M. Physical activity and progression of carotid intima-media thickness in patients with coronary heart disease. J Cardiol 51 (2008) 157-162
17. Kato M., Dote K., Habara S., Takemoto H., Goto K., and Nakaoka K. Clinical implications of carotid artery remodeling in acute coronary syndrome: ultrasonographic assessment of positive remodeling. J Am Coll Cardiol 42 (2003) 1026-1032
18. Hiki M., Shimada K., Ohmura H., Kiyanagi T., Kume A., Sumiyoshi K., Fukao K., Inoue N., Mokuno H., Miyazaki T., and Daida H. Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease. J Cardiol 53 (2009) 108-116
19. The Examination Committee of Criteria for Metabolic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Int Med 94 (2005) 794-809
20. Friedewald W.T., Levy R.I., and Frederickson D.S. Estimation of low density lipoprotein cholesterol without the use of the preparative centrifuge. Clin Chem 18 (1972) 499-502
21. Kato M., Shiode N., Yamagata T., Matsuura H., and Kajiyama G. Coronary segmental responses to acetylcholine and bradykinin in patients with atherosclerotic risk factors. Am J Cardiol 80 (1997) 751-755
22. Ambrose J.A., Winters S.L., Stern A., Eng A., Teichholz L.E., Gorlin R., and Fuster V. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 5 (1985) 609-616
23. Rehr R., Disciascio G., Vetrovec G., and Cowley M. Angiographic morphology of coronary artery stenoses in prolonged rest angina: evidence of intracoronary thrombosis. J Am Coll Cardiol 14 (1989) 1429-1437
24. Barter P., Gotto A.M., LaRosa J.C., Maroni J., Szarek M., Grundy S.M., Kastelein J.J., Bittner V., and Fruchart J.C. Treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357 (2007) 1301-1310
25. Fernandez M.L., and Webb D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr 27 (2008) 1-5
26. Rosenson R.S. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 22 (1993) 933-940
27. Pitt B., Loscalzo J., Ycas J., and Raichlen J.S. Lipid levels after acute coronary syndromes. J Am Coll Cardiol 51 (2008) 1440-1445
28. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto Jr. A.M., Kastelein J.J., Koenig W., Libby P., Lorenzatti A.J., MacFadyen J.G., Nordestgaard B.G., Shepherd J., Willerson J.T., Glynn R.J., and JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
29. Tsimikas S., Willerson J.T., and Ridker P.M. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47 (2006) C19-C31